Arab Board Dermatology Part 1 study materials
Arab Board Dermatology Part 1 study resources

Arab Board Dermatology Part 1: Skin Tumors and Cutaneous Oncology

Arab Board Dermatology Part 1 · Work through your exam, one topic at a time.

All guide sections

Skin Tumors and Cutaneous Oncology

Core concepts

Separate benign, premalignant, and malignant lesions and know the pathway for each. Basal cell carcinoma (BCC): pearly, telangiectatic, slow-growing, rarely metastasises. Squamous cell carcinoma (SCC): keratotic, ulcerated, risk of metastasis, preceded by actinic keratosis. Melanoma: ABCDE and the Breslow thickness as the key prognostic factor. Know the dermoscopic hallmarks (atypical network, blue-white veil, irregular dots/globules, regression).

Also learn: actinic keratosis and Bowen disease as SCC precursors; dermatofibroma and seborrheic keratosis as benign mimics; cutaneous lymphoma (mycosis fungoides with Pautrier microabscesses, Sézary syndrome) and Kaposi sarcoma (HHV-8).

Traps

  • Confusing Breslow thickness (prognosis) with Clark level (invasion depth by layer).
  • Assuming all pigmented lesions need excision - dermoscopy guides.
  • Missing that SCC in immunosuppressed or transplant patients behaves aggressively.
  • Nodular melanoma may lack pigment and present as a rapidly growing nodule.

Rule of thumb

For melanoma questions, the single most important prognostic variable is Breslow thickness; for management questions, margin depends on thickness. For non-melanoma skin cancer, ask whether the lesion is low- or high-risk by site, size, histology, and immunosuppression.